- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Glenmark Pharma's U.S. arm to launch Leucovorin Calcium Injection in the U.S. Market | 2 | capitalmarket.com | ||
| 01.12. | Glenmark Pharmaceuticals: Cosmo and Glenmark Announce Market Authorisation of Winlevi (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe | 460 | PR Newswire | DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission... ► Artikel lesen | |
| 01.12. | Glenmark Pharma's Chhatrapati Sambhajinagar facility clears USFDA inspection with zero observations | 3 | capitalmarket.com | ||
| 27.11. | Drugmaker Glenmark Pharma Receives Establishment Inspection Report From US Health Regulator For Formulations Manufacturing Facility In North Carolina | 3 | The Free Press Journal | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 27.11. | Glenmark Pharmaceuticals Ltd up for third straight session | 2 | capitalmarket.com | ||
| 27.11. | Glenmark Pharma gains after receiving positive USFDA EIR for Monroe Facility | 6 | capitalmarket.com | ||
| 25.11. | Glenmark gains after launching first-ever nebulized triple therapy for COPD | 4 | capitalmarket.com | ||
| 19.11. | Stocks to buy in 2025 for long term: Sun Tv, Glenmark Pharma among 5 stocks that could give 17-33% return | 4 | Times of India | ||
| 18.11. | Glenmark Pharma gets EC nod for acne drug Winlevi in 15 European countries | 3 | capitalmarket.com | ||
| 17.11. | Glenmark Pharma gains after Q2 PAT climbs 72% YoY to Rs 610 cr | 2 | capitalmarket.com | ||
| 15.11. | Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr | 4 | capitalmarket.com | ||
| 15.11. | Glenmark Pharmaceuticals Reports 72.2% Jump In Profit After Tax At Rs 610.43 Crore Due To Licensing Deal With AbbVie | 14 | The Free Press Journal | ||
| 14.11. | Glenmark Pharmaceuticals Ltd spurts 2.55%, gains for third straight session | 3 | capitalmarket.com | ||
| 04.11. | Glenmark Pharma's US subsidiary to launch 8.4% sodium bicarbonate injection in US market | 2 | capitalmarket.com | ||
| 03.11. | Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session | 4 | capitalmarket.com | ||
| 30.10. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 3 | capitalmarket.com | ||
| 30.10. | Import von Glenmark: Engpass: Salbutamol aus Brasilien | 3 | APOTHEKE ADHOC | ||
| 23.10. | Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US | 3 | capitalmarket.com | ||
| 28.09. | Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA | 2 | ZEE Business | ||
| 26.09. | Fierce Pharma Asia-Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal | 6 | FiercePharma |
1 2 3 4 Weiter >>
78 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,210 | -0,90 % | Sinopharm Group-Aktie heute gut behauptet: Aktienwert steigt (2,08 €) | Der Anteilsschein der Sinopharm Group notiert heute ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 2,08 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 11.09.2025 Freuen können... ► Artikel lesen | |
| CSPC PHARMA | 0,853 | -0,37 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - NEW INDICATION FOR DUOENYI (IRINOTECAN HYDROCHLORIDE LIPOSOME INJECTION) OBTAINS MARKETING APPROVAL | ||
| WUXI BIOLOGICS | 3,664 | -1,76 % | WuXi Biologics-Aktie leicht im Plus (4,441 €) | Das Wertpapier von WuXi Biologics notiert heute fester. Das Papier kostete zuletzt 4,44 Euro. Ein Preisanstieg in Höhe von 17 Cent erfreut derzeit die Aktionäre von WuXi Biologics. Zur Stunde kostet... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,392 | -3,39 % | Milliarden für Metsera & Fosun Pharma: Pfizers Schicksalsjahre beginnen | Die Pfizer-Aktie steht aktuell bei 21 EUR - ein Niveau, das die Unsicherheit der letzten zwei Jahre widerspiegelt. Nach dem steilen Absturz der COVID-Umsätze kämpft der Pharmariese darum, sein Portfolio... ► Artikel lesen | |
| GEDEON RICHTER | 24,860 | -2,89 % | Gedeon Richter Plc.: Corporate Action Timetable | ||
| DR REDDYS | 11,700 | +0,86 % | Immutep And Dr. Reddy's Strike Deal For Cancer Drug Efti | CANBERA (dpa-AFX) - Immutep Limited (IMMP) and Dr. Reddy's Laboratories Ltd. (RDY) on Monday said their subsidiaries have agreed to partner on the development and commercialisation of Eftilagimod... ► Artikel lesen | |
| ASPEN PHARMACARE | 4,700 | +2,62 % | Dividendenbekanntmachungen (01.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRES COMMERCIAL REALTY CORP PFD D US00489Q3002 0,4921 USD 0,4193 EUR AECOM US00766T1007 0,26 USD 0,2215 EUR AFRICAN RAINBOW MINERALS... ► Artikel lesen | |
| LUYE PHARMA | 0,316 | +1,28 % | LUYE PHARMA (02186): DISCLOSEABLE TRANSACTION COMPLETION OF THE ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY | ||
| SHANGHAI PHARMACEUTICALS | 1,360 | +3,82 % | SH PHARMA (02607): IMPLEMENTATION RULES OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,137 | 0,00 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT -XUANYUENING, AN INNOVATIVE DRUG, FIRST INCLUDED IN THE NRDL | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,515 | +5,97 % | CHINARES PHARMA (03320): CONTINUING CONNECTED TRANSACTIONS THE AMENDED BUSINESS TRAVEL SERVICES FRAMEWORK AGREEMENT 2026 | ||
| HANSOH PHARMACEUTICAL | 4,740 | +0,42 % | HSI Up 348 pts; HSTI Up 80 pts; CHINAHONGQIAO Up over 3%; PING AN, HSBC HOLDINGS, HANSOH PHARMA, HYSAN DEV Hit New Highs | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,920 | +0,55 % | Dividendenbekanntmachungen (09.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,1348 HKD 0,0147 EUR AMEREN CORPORATION US0236081024 0,71 USD 0,6037 EUR ANHUI... ► Artikel lesen | |
| KALBE FARMA | 0,054 | +1,89 % | Kalbe Farma profit rises 10.63%, shares react positively: The shares of this Indeks52 constituent climb 3.25% ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.